Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q2 2026Earnings call Jul 15, 2026 · most recent call
ELV’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: Elevance Health’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: ELV daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
No 8-K events recorded since this call day.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
Reporting soon: earnings call Wednesday, Oct 21
A pre-earnings brief is ready for ELV: the setup, what peers and partners said this season, and which analysts to watch.Reading it is a Tellvest Pro feature.
Full Pro access for 30 days when you create a free account. No credit card required.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $45.44B | +6.6% | $1.81 | -50.1% | 2.1% | 0.9% | $384M |
| FY2025 Q1 | $48.89B | +14.8% | $9.61 | +0.2% | 6.4% | 4.5% | $821M |
| FY2025 Q2 | $49.78B | +14.0% | $7.72 | -21.6% | 5.3% | 3.5% | $1.79B |
| FY2025 Q3 | $50.71B | +12.3% | $5.32 | +22.0% | 3.5% | 2.3% | $775M |
| FY2025 Q4 | $49.75B | +9.5% | $2.47 | +36.5% | 1.2% | 1.1% | $-209M |
| FY2026 Q1 | $50.18B | +2.6% | $8.00 | -16.8% | 5.3% | 3.5% | $4.10B |
| FY2026 Q2Selected | $50.47B | +1.4% | $6.71 | -13.1% | 4.1% | 2.9% | $1.63B |
Management-stated figures from ELV’s newest call are part of Tellvest Pro.